Is The Value of FDG PET/CT in Evaluating Renal Metastasis Underestimated? A Case Report and Review of The Literature
Authors:
- Fuat DedeFDFuat Dede
- Sabahat İnAnırSISabahat İnAnır
- Tanju Yusuf ErdilTETanju Yusuf Erdil
Open Access
- 5 December 2013
- journal article
- review article
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 22 (3) , 109-112
Abstract
Contrast-enhanced CT or MRI are used as a gold standard imaging modalities in the detection and characterization of renal masses. On the other hand, the role of FDG PET/CT in evaluating primary or metastatic cancers of the kidney is limited due to the excretion of FDG through urinary tract. We reported the FDG PET/CT of a lung cancer patient with multiple metastases in both kidneys which were missed in previous PET/CT, and underestimated on sequential diagnostic abdominal CT study. None declared.Keywords
This publication has 10 references indexed in Scilit:
- Synchronous Renal Masses in Patients With a Nonrenal Malignancy: Incidence of Metastasis to the Kidney Versus Primary Renal Neoplasia and Differentiating Features on CTAmerican Journal of Roentgenology, 2011
- Contemporary Radiologic Imaging of Renal Cortical TumorsUrologic Clinics of North America, 2008
- Pitfalls in Renal Mass Evaluation and How to Avoid ThemRadioGraphics, 2008
- Evaluation of Renal MassesJournal of the American College of Radiology, 2008
- Cross-sectional Imaging Evaluation of Renal MassesRadiologic Clinics of North America, 2008
- Clinical Use of Fluorodeoxyglucose F 18 Positron Emission Tomography for Detection of Renal Cell CarcinomaJournal of Urology, 2004
- Secondary renal neoplasmsAbdominal Radiology, 1998
- FDG PET characterization of renal masses: Preliminary experienceClinical Radiology, 1997
- Renal Metastases from Carcinoma of the LungBritish Journal of Urology, 1986
- Pulmonary Cancer Metastatic to the Kidney—a Common Renal NeoplasmJournal of Urology, 1971